Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCCAP.L Regulatory News (CCAP)

  • There is currently no data for CCAP

Interim Management Statement

12 Jul 2013 07:00

RNS Number : 1606J
Charlemagne Capital Limited
12 July 2013
 



12 July 2013

 

 

Interim Management Statement for the Six Months Ended 30 June 2013

 

 

Charlemagne Capital Limited ("Charlemagne" or the "Group") sets out below the key Revenue items and Assets under Management ("AuM") for the first six months of its current financial year.It is expected that the interim financial results will be announced on 17 September 2013.

 

Key highlights and Group AuM

 

§ As at 30 June 2013, Group AuM were US$2.4 billion, down by 8.1% since 1 January 2013;

 

§ Net management fees of US$11.9 million, up 10.2% on the previous six months;

 

·; The Group remains well-capitalised with a strong and liquid balance sheet; and

 

·; Strong relative performance in key investment strategies.

 

 

The table below sets out the Group's AuM as at 30 June 2013 and the movements experienced in each product range in the period since 1 January 2013.

 

01-Jan-13

Net Subscriptions

Net Performance

30-Jun-13

Movement In

AuM (US$m)

(US$m)

(%)

(US$m)

(%)

AuM (US$m)

Period (%)

Magna

364

86

23.6

(30)

(7.4)

420

15.4

OCCO

597

(36)

(6.0)

25

4.3

586

(1.8)

Institutional

1,526

(113)

(7.4)

(125)

(8.5)

1,288

(15.6)

Specialist

145

(17)

(11.7)

(4)

(2.9)

124

(14.5)

Total

2,632

(80)

(3.0)

(134)

(5.2)

2,418

(8.1)

 

Notes:

Closing AuM is stated as including all subscription and redemption orders received for the relevant funds as at the close of the period but not processed until the first dealing date of the following period.

 

Unaudited revenue numbers for the six months ended 30 June 2013

 

Net management fees receivable were US$11.9 million compared with US$10.8 million for the previous six months and US$9.7 million for the comparable period of 2012, reflecting the higher average AuM over the period of US$2.6 billion compared with US$2.4 billion in 2012 and a small increase in net margin arising from the greater proportion of OCCO higher fee classes that have been present for the full period. OCCO management fees, which are subject to a minority interest, account for nearly 44% of total net fee income during the period.

 

Crystallised performance fees were US$0.5 million compared with US$0.9 million for the comparative period in 2012. Accruing performance fees1 for 2013 which have not crystallised were US$5.9 million, principally from OCCO, compared with US$3.5 million as at the same date in 2012.

 

 

_________________________________________________________________________

1Performance fees accrue throughout the reporting period in the accounts of each relevant fund. It is the group's accounting policy only to recognise such revenues as they crystallise at the year-end date of the fund or, in certain cases, on redemption. Levels of accrued performance fees at any particular time should not be seen as necessarily indicative of the eventual crystallised figures, especially in periods of above average market volatility.

 

Dividend

 

In the absence of unforeseen circumstances, the Group intends to declare an interim dividend in respect of the six months to 30 June 2013. Further details will be provided in the interim results announcement planned for 17 September 2013.

 

Summary

 

Emerging markets have returned a negative performance over the period with the greatest falls in value occurring in June, when the MSCI Emerging markets index was down by 6.4% for the month resulting in a 9.6% ( in US$) drop over the full half year.

 

Over the period, the relative performance of Charlemagne's key equity strategies has been strong, with seven of the nine Magna sub-funds in the top half of their FactSet Morningstar peer group. Notably, theMagna Emerging Markets Dividend Fund, which has a full three year track record as of June 2013, has achieved first quartile performance over all periods since inception and has outperformed the MSCI EM index by 7.6% for the year to date with lower volatility than the index.

 

The positive net inflows into the Magna funds over the first half of the year are predominantly due to subscriptions into the Magna Emerging Markets Dividend Fund. The institutional business benefitted from the acquisition of a new US$45 million Eastern European mandate and US$60 million from existing mandates. However a partial asset reallocation from a long standing mandate, together with outflows from sub advisory business caused the overall net flows to be negative in this category. The OCCO Eastern European Fund also suffered net outflows as some investors reassessed their exposure to the asset class.

 

Outlook

 

In the last quarter of 2012, emerging markets began to outperform developed markets after a period of two years when they had lagged. Inflows returned to the asset class and the outlook was optimistic. The outperformance has reversed in 2013 as not only have emerging markets produced negative returns, but they have also again underperformed developed markets. Momentum has stalled as investors have reassessed asset allocations and industry flows have been negative. Despite strong relative performance our asset values have consequently fallen over the period. Although the Group remains profitable overall in the year to date, an increase in AuM is required in order to ensure sustainable profits on a recurring management fee basis. Under current circumstances, the generation of performance fees during the remainder of the year will be a significant factor in determining full year profit levels. We are reviewing the cost base but are committed to preserving the necessary infrastructure required to service our investors and for future expansion.

 

We believe that, although markets will remain volatile now that the issue of reduced Central Bank support to liquidity is out in the open, there are still reasons for a positive outlook. Equity markets have overreacted and have quickly over discounted a worst possible outcome. Deflationary forces are still such that meaningful interest rate hikes are a long way off and valuations are sufficiently below average to suggest returns from such levels should typically be strong over subsequent 12-18 month periods.

 

 

Enquiries:

 

Charlemagne Capital

 

Jayne Sutcliffe, Chief Executive

Tel. 020 7518 2100

Lloyd Jones, Finance Director

Tel. 01624 640200

 

 

N+1 Singer

+44 020 7496 3000

Jonny Franklin-Adams

Nick Donovan

 

 

 

Smithfield Consultants

Tel. 020 7360 4900

John Kiely

 

 

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSKMGMNKMLGFZM
Date   Source Headline
14th Jan 20147:00 amRNSTrading Statement
11th Oct 20133:28 pmRNSQ3 2013 AUM Update
17th Sep 20139:52 amRNSDividend Declaration
17th Sep 20137:00 amRNSHalf Yearly Report
10th Sep 20134:59 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
22nd Aug 20136:08 pmRNSNotification of Significant Shareholding
12th Jul 20137:00 amRNSInterim Management Statement
8th Jul 20136:03 pmRNSNotification of Significant Shareholding
25th Jun 201310:14 amRNSChange in Significant Interest
20th Jun 201312:02 pmRNSChange in Significant Shareholding
13th Jun 201312:40 pmRNSResult of AGM
20th May 20134:49 pmRNSAnnual Report and Notice of AGM
26th Mar 20139:00 amRNSDividend Declaration
26th Mar 20137:00 amRNSFinal Results
6th Feb 20134:40 pmRNSSecond Price Monitoring Extn
6th Feb 20134:35 pmRNSPrice Monitoring Extension
23rd Jan 20134:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20134:35 pmRNSPrice Monitoring Extension
22nd Jan 20137:00 amRNSAppointment of Sole Broker
21st Jan 20139:34 amRNSNotification of Major Interest in Shares
5th Nov 20127:00 amRNSAdviser Change of Name
11th Oct 201210:15 amRNSSignificant Shareholding Announcement
10th Oct 20129:46 amRNSQ3 2012 AUM Update (Replacement)
10th Oct 20127:00 amRNSQ3 2012 AUM Update
18th Sep 20127:00 amRNSResults for the six months to 30 June 2012
11th Jul 20127:00 amRNSInterim Management Statement
27th Jun 201211:14 amRNSDirector Declaration
14th Jun 20123:21 pmRNSAGM Statement
10th May 20129:58 amRNSNotice of AGM
4th May 20122:00 pmRNSDirector/PDMR Shareholding
27th Apr 201212:58 pmRNSEuropean Convergence Development Company PLC
5th Apr 20124:04 pmRNSDirector/PDMR Shareholding
5th Apr 20127:00 amRNSAUM update
29th Mar 20125:59 pmRNSDirectors Dealings
29th Mar 20127:00 amRNSDirector/PDMR Shareholding
20th Mar 20128:15 amRNSDividend Declaration
20th Mar 20127:00 amRNSFinal Results
12th Jan 20127:00 amRNSTrading Statement
7th Oct 20117:00 amRNSAssets under Management
30th Sep 201112:41 pmRNSNotification of Major Interest in Shares
23rd Sep 20113:46 pmRNSSignificant Shareholding
24th Aug 20117:00 amRNSSignificant Shareholding
5th Aug 20114:40 pmRNSSecond Price Monitoring Extn
5th Aug 20114:35 pmRNSPrice Monitoring Extension
7th Jul 20117:00 amRNSTrading Statement
5th Jul 201111:54 amRNSChange to Significant Shareholding
10th Jun 20117:00 amRNSBusiness Update Announcement
25th May 20114:40 pmRNSSecond Price Monitoring Extn
25th May 20114:35 pmRNSPrice Monitoring Extension
13th May 201112:36 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.